Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Mylan Reforms As It Prepares To Become Viatris
Viatris Chosen As Name For Merged Entity
Nov 15 2019
•
By
Aidan Fry
Mylan is reforming its portfolio, pipeline and supply chain as it prepares to merge with Upjohn to form Viatris • Source: Shutterstock
More from Manufacturing
More from Business